ISPOR ASIA-PACIFIC MEDICAL DEVICE & DIAGNOSTICS COUNCIL MEMBERS

ISPOR Asia-Pacific Medical Device & Diagnostics Council Officers:

2008-2010 Chair/Vice Chair:

CHEN Jie PhD, Director, Key Leb of Health Technology Assessment, Consultant, National Institute of Hospital Administration, Professor, School of Public Health, Fudan University, Shanghai, P.R. China
Email: jchen@shmu.edu.cn

Madeleine R. Valera MD, MScIH (Heidelberg), Senior Vice President for Health Finance Policy and Services Sector, Philippine Health Insurance Corporation, Pasig City, Philippines
Email: tgm@philhealth.gov.ph

ISPOR Asia-Pacific Medical Device & Diagnostics Council Members

CHINA (MAINLAND)
Government:

TANG Xiaoli MSc, MA,
Deputy Chief, Policy Davison, Medical Insurance Department, Ministry of Labor & Social Security,  Beijing, P.R. China

Academia:
CHEN Jie PhD, Director, Key Leb of Health Technology Assessment, Consultant, National Institute of Hospital Administration, Ministry of Health, P.R. China, Professor, School of Public Health, Fudan University, Shanghai, P.R.China

Yingyao Chen PhD, MD, MPH, Associate Professor, Health Technology Assessment & Research Center, Department of Hospital Management, School of Public Health, Fudan University, Shanghai, P.R.China

TAIWAN
Government:
LEE Cheng-Hua MD, PhD, Vice President & C.I.O., Bureau of National Health Insurance, Department of Health

Academia:
KAO Hsien-Li MD, Department of Internal Medicine, National Taiwan University Hospital, Advisory Board, Taiwan Society of Cardiovascular Intervention, Taipei, Taiwan

YANG Ming-Chin PhD, Associate Professor, Medical Administration Institute, National Taiwan University, Taipei, Taiwan

Hospital
TARN Yen-Huei (Tony) MS, PhD, Chairman, Department of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan

JAPAN
Government:
Toshio Nagae, President of CMIC MPSS, (Marketing Promotion & Sales Support), And that of PCN, Patient Community Network, Tokyo, Japan

Academic:
Isao Kamae MD, DrPH, Professor and Chair, Graduate School of Health Management, Keio University, Tokyo, Japan
4411 Endo, Fujisawa-City, Kanagawa 252-8530, Japan

MALAYSIA
Hospital:
SIM Kui-Hian MBBS, Head, Department of Cardiology, Head, Clinical Research Centre (CRC), Sarawak General Hospital, Adjunct Professor, Faculty of Medicine & Health Sciences, University Malaysia Sarawak (UNIMAS), Sarawak, Malaysia

LIM Teck Onn PhD, Head, Clinical Research Centre, Kuala Lumpur Hospital, Ministry of Health, Kuala Lumpur, Malaysia

PHILLIPINES
Government:
Madeleine R. Valera MD, MScIH (Heidelberg), Senior Vice President for Health Finance Policy and Services Sector, Philippine Health Insurance Corporation, Pasig City, Philippines

Agnette P. Peralta Director, Bureau of Health Devices and Technology, Department of Health, Philippines, Manila, Philippines

SINGAPORE
Academia:
PHUA Kai Hong AB SM PhD, Joint Professor, Health Policy and Management, Lee Kuan Yew School of Public Policy
National University of Singapore, Singapore

LIM Meng Kin Community Occupational & Family Medicine, National University of Singapore, Singapore

Hospital:
LIM Yean Teng, Consultant Cardiologist, Cardiology Associates

SOUTH KOREA
Academic:
KANG Hye-Young RPh, PhD
, Professor of Health Policy and Administration, School of Public Health, Yonsei University, Seoul, South Korea

Industry & Other Organizations

WANG Huimin, Corporate Vice Presidnet, Edwards Lifesciences, 2-8 Rokubancho, Tokyo, Japan

Ashoke Bhattacharjya PhD, Executive Director, Health Outcomes and Policy, Johnson & Johnson Medical Asia Pacific

LEE Sang Soo BA, Reimbursement Manager, Medtronic Korea Co., Ltd., Seoul, South Korea

George Faithfull, Vice President, Regulatory Affairs and Quality Assurance, Stryker Pacific, NSW 2065, Australia

Han Dehui (Davey), MS, MD, General Manager, Regulatory Affairs and Quality Management, Siemens China Ltd Medical Solutions Group,
Beijing, P. R. China

GUAN Zhiqiang MD, MPH, Director, Public Affairs and Policy, Pfizer Inc. (China), Beijing, P. R. China

Anna Xi Zhao, MBA, Msc, MB BS, Trade & Investment Manager (LifeSciences), British Embassy Beijing, Beijing, P.R.China

Council Advisory Committee Directory 

2008-2010 Chair

Miguel Valentin, Director, Health Economics – International, Boston Scientific Corporation, One Boston Scientific Place, Natick, MA 01760, USA 
E-mail: valentim@bsci.com

Committee Members

Paul Barry, Boston Scientific, Pennsylvania Ave, NW, Suite 5505, Washington, DC 20004, USA

Jeff Farkas, Sr. Director, Health Policy & Payment, Medtronic, Inc., Washington, DC USA

Stephen Hull, Vice President, Global Strategy & Analysis Dept, Advanced Medical Technology Association (AdvaMed), Washington, DC, USA

KHOO Teng Chuan PhD, Vice President, Strategic Medical Affairs, Johnson & Johnson Medical Asia-Pacific, Singapore

Craig Kramer, Vice President, Government Affairs, Johnson & Johnson, New Brunswick, NJ USA

Chris Miller, Sr. Director, Healthcare Economics - Asia Pacific, Medtronic, Inc, Tokyo, Japan

Comodio Shiodome 5F 2-14-1 Higashi-Shimbashi, Minato-ku, Tokyo 105-0021, Japan

For more information please contact: apmddcouncil@ispor.org
 


 Asia-Pacific Medical Device and Diagnostics Council main page

Contact ISPOR @ info@ispor.org  |  View Legal Disclaimer
©2008 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.
 
Website design by Eagle Systems USA, Inc.